中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
Qizheng Tibetan Medicine has received an A-level rating in the Shenzhen Stock Exchange’s information disclosure assessment for six consecutive years.
2021-07-14
The All-China Federation of Industry and Commerce held a special event to celebrate the 100th anniversary of the founding of the Communist Party of China. Lei Jufang, Chairwoman of Qizheng Tibetan Medicine, delivered the keynote speech.
2021-06-27
Greenhouse Gas Verification Statement
2021-04-28
Product strategy yields results: Qizheng Tibetan Medicine’s net profit grew by 11% in 2020, and the company plans to distribute a cash dividend of 3.4 yuan for every 10 shares held.
2021-04-16
Expanding into pharmaceutical retail: Qizheng Tibetan Medicine plans to participate in the establishment of a fund dedicated to investing in Baiyunshan Yixintang.
2021-03-10
The Trinity: Tibetan Medicine Enterprises “Generate Blood” to Alleviate Poverty
2021-01-21
Qizheng Tibetan Medicine’s exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, have been included in the National Medical Insurance Catalog.
2020-12-30
Lei Jufang, Chairwoman of Qizheng Tibetan Medicine, was named a “2020 UN Sustainable Development Goals China Pioneer.”
2020-12-11
Qizheng Tibetan Medicine Wins the 22nd Golden Bull Award for Investor Relations Management among Listed Companies.
2020-11-19
The Qizheng Tibetan Medicine Social Responsibility Report has been selected as one of the 100 Outstanding Corporate Social Responsibility Reports by the Ministry of Industry and Information Technology of China.
2020-11-07
Qizheng Tibetan Medicine’s 800 million yuan convertible bond is set to be listed soon, which will help break through capacity bottlenecks and continue expanding its marketing network.
2020-10-26
Qizheng Tibetan Medicine has been awarded the 2020 China Greater Health Industry “Sunshine” – Industry Benchmark Enterprise Award.
2020-09-27
Qizheng Tibetan Medicine Wins Two Awards at the CSR China Education Awards
2020-09-11
Qizheng Tibetan Medicine (002287) Wins the “China Listed Companies Social Responsibility Award”
2020-08-28
Qizheng Tibetan Medicine Forges a Sustainable Brand Through Responsibility
2020-08-10